Actavis Wins Patent Appeal for Generic to Teva’s Fentora

Actavis Inc.’s generic version of the painkiller Fentora wouldn’t infringe two patents owned by Teva Pharmaceutical Industries Ltd.’s Cephalon unit, a U.S. appeals court ruled today.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.